Pharma IT and AI – 2024 Health IT Predictions
Healthcare IT Today
JANUARY 8, 2024
Given the improvements in costs, trial sponsors can now take advantage of these exchanges at scale and leverage the data for both pre-screening and health economic analysis. As DCTs and virtual site acceptance accelerates, a knock-on effect will be that more of these trials will include HEOR analysis.
85 
Let's personalize your content